Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Clinical trial NCT00660101 · UNKNOWN

Trial details

NCT number: NCT00660101
Sponsor: AVAX Technologies
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Ovary

Start date: 2008-06-01
Primary completion: 2015-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.